Logo image of AFJKR

AIMEI HEALTH TECHNOLOGY CO L (AFJKR) Stock Price, Quote, News and Overview

NASDAQ:AFJKR - Nasdaq - KYG013411338 - Currency: USD

0.2539  0 (-0.31%)

Fundamental Rating

2

Overall AFJKR gets a fundamental rating of 2 out of 10. We evaluated AFJKR against 0 industry peers in the Unkown industry. The financial health of AFJKR is average, but there are quite some concerns on its profitability. AFJKR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

AFJKR had positive earnings in the past year.
In the past year AFJKR has reported a negative cash flow from operations.
AFJKR Yearly Net Income VS EBIT VS OCF VS FCFAFJKR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 50K 100K 150K

1.2 Ratios

Industry RankSector Rank
ROA 4.02%
ROE 4.06%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AFJKR Yearly ROA, ROE, ROICAFJKR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 0.05 0.1 0.15 0.2

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AFJKR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AFJKR Yearly Profit, Operating, Gross MarginsAFJKR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

5

2. Health

2.1 Basic Checks

There is no outstanding debt for AFJKR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AFJKR Yearly Shares OutstandingAFJKR Yearly Shares OutstandingYearly Shares Outstanding 2022 2M 4M 6M
AFJKR Yearly Total Debt VS Total AssetsAFJKR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 1.18, we must say that AFJKR is in the distress zone and has some risk of bankruptcy.
There is no outstanding debt for AFJKR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.18
ROIC/WACCN/A
WACCN/A
AFJKR Yearly LT Debt VS Equity VS FCFAFJKR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 20M 40M 60M

2.3 Liquidity

A Current Ratio of 6.13 indicates that AFJKR has no problem at all paying its short term obligations.
A Quick Ratio of 6.13 indicates that AFJKR has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 6.13
Quick Ratio 6.13
AFJKR Yearly Current Assets VS Current LiabilitesAFJKR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 100K 200K 300K 400K 500K

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AFJKR Yearly Revenue VS EstimatesAFJKR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023
AFJKR Yearly EPS VS EstimatesAFJKR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.79, the valuation of AFJKR can be described as very cheap.
AFJKR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.35.
Industry RankSector Rank
PE 0.79
Fwd PE N/A
AFJKR Price Earnings VS Forward Price EarningsAFJKR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AFJKR Per share dataAFJKR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AFJKR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AIMEI HEALTH TECHNOLOGY CO L

NASDAQ:AFJKR (3/7/2025, 4:30:00 PM)

0.2539

0 (-0.31%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners103.98%
Inst Owner ChangeN/A
Ins Owners2.48%
Ins Owner ChangeN/A
Market Cap1.55M
AnalystsN/A
Price TargetN/A
Short Float %0.56%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.79
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.02
P/tB 0.02
EV/EBITDA N/A
EPS(TTM)0.32
EY126.03%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS11.52
TBVpS11.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.02%
ROE 4.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.13
Quick Ratio 6.13
Altman-Z 1.18
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A